Health CanadaGeneral Alert
ZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encep...
Published: March 16, 2018Recall ID: 60756Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
ZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis
Additional Source Details
| Field | Value |
|---|---|
| N I D | 60756 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/zinbryta-daclizumab-beta-voluntary-withdrawal-canada-due-risk-encephalitis |
| Issue | Product safety |
| Title | ZINBRYTA (daclizumab beta) - Voluntary Withdrawal in Canada due to Risk of Encephalitis |
| Archived | 0 |
| Category | Biologic or vaccine |
| Last updated | 2018-03-16 |
| Organization | Marketed health products |